During the past year, awareness of GLP-1 drugs among consumers has grown exponentially. However, attitudes surrounding these injections are split: FMCG Gurus’ research has revealed that 41% of consumers hold a positive opinion whereas 40% have a negative one.
It’s important for manufacturers and marketers alike to understand where these perceptions are coming from and how consumer attitudes and behaviours will affect the market heading forward.